You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
While looking at lineages circulating in Germany
kindly highlighted to me by Josette Shoenmakers
i was curious about the ongoing circulation of AY.129.
So looking at this lineage more closely i found one with an apparent growth advantage in comparison to the parental one.
Mutations: Orf1b:1087Y (nuc:C16726T) then Orf1a:2097T (nuc:G6554A) and nuc: C3695T,A27753G
Number of Sequences: 1627
First sequence: Germany W 37/2021
Countries: Germany (1200seq) , Switzerland (100seqs), Luxembourg (100Seqs)
Prevalence in Germany 1-29 January 2022: 0,68%
Growth Advantage in comparison to AY.129* (Last 6 Months, Global): +20%
Growth advantage vs AY.4.2* (between 1 July-30 november 2021) +11%:
While looking at lineages circulating in Germany
kindly highlighted to me by Josette Shoenmakers
i was curious about the ongoing circulation of AY.129.
So looking at this lineage more closely i found one with an apparent growth advantage in comparison to the parental one.
Mutations: Orf1b:1087Y (nuc:C16726T) then Orf1a:2097T (nuc:G6554A) and nuc: C3695T,A27753G
Usher Tree
Number of Sequences: 1627
First sequence: Germany W 37/2021
Countries: Germany (1200seq) , Switzerland (100seqs), Luxembourg (100Seqs)
Prevalence in Germany 1-29 January 2022: 0,68%
Growth Advantage in comparison to AY.129* (Last 6 Months, Global): +20%
Growth advantage vs AY.4.2* (between 1 July-30 november 2021) +11%:
Global overview CovsSpectrum
The text was updated successfully, but these errors were encountered: